Erlotinib Tablets IP

Name: Erlotinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 2300 INR
Availability: InStock

Price 2300 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Erlotinib Tablets IP Specification

Dosage Form
Tablet

Salt Composition
Erlotinib Hydrochloride

Indication
Non-Small Cell Lung Cancer, Pancreatic Cancer

Feature
Film-coated, easy to swallow

Ingredients
Erlotinib Hydrochloride, Excipients

Application
Anti-cancer therapy

Physical Color/Texture
White to off-white tablets

Fermentation Smell
Odorless

Storage Instructions
Store at room temperature, below 30°C, in a dry place

Shelf Life
24 months

Packaging Size
30 tablets per box

Prescription Status
Prescription only (Rx)

Strength
100 mg / 150 mg

Warning
To be sold by retail on the prescription of oncologist only

ATC Code
L01EB02

Country of Approval
India

Moisture Content
<5%

Batch Number
Available on packaging

Marketed By
As per product label

Route of Administration
Oral

MRP
As per current market rates

About Erlotinib Tablets IP

Redeem your hope with praiseworthy Erlotinib Tablets IP, a famed solution offering targeted relief for Non-Small Cell Lung Cancer and Pancreatic Cancer. Available in potent strengths of 100 mg and 150 mg, each box contains 30 sensational, film-coated tablets-fresh and easy to swallow. Crafted with Erlotinib Hydrochloride, these tablets are strictly prescription-only and suitable for oral administration. Grab yours from leading distributors, exporters, and suppliers across India. Moisture-protected for premium efficacy; batch details and MRP as per packaging. Only dispensed after oncologist consultation.

Therapeutic Applications and User Profile

Erlotinib Tablets IP is used extensively in anti-cancer therapy, specifically for Non-Small Cell Lung Cancer and Pancreatic Cancer. Used by oncologists and prescribed to adult patients, these tablets are recognized for their efficacy. Beyond primary indications, ongoing research explores other oncological applications. This prescription medication is distributed to reputed hospitals, clinics, and pharmacies across India, ensuring reliable access for eligible patients in need of advanced cancer support.

Payment, Samples, and Domestic Market Reach

Premium satisfaction meets convenience with Erlotinib Tablets IP. Interested buyers can request samples, subject to the proposal amount and standard conditions. Asking price aligns with current market rates, ensuring accessibility without compromising quality. Payment terms are flexible, with options tailored for both bulk distributors and medical professionals. The main domestic market focus remains India, where these tablets are distributed to registered retailers and institutions, reinforcing nationwide availability for authorized medical use.

FAQ's of Erlotinib Tablets IP:

Q: How should Erlotinib Tablets IP be administered for the best results?

A: Erlotinib Tablets IP should be taken orally, as prescribed by a qualified oncologist, ideally on an empty stomach or at least one hour before or two hours after meals.

Q: What conditions are Erlotinib Tablets IP indicated for?

A: These tablets are indicated for the treatment of Non-Small Cell Lung Cancer and Pancreatic Cancer, under strict medical supervision.

Q: When can I expect to receive the product after placing an order?

A: Delivery timelines vary based on stock availability and location, but orders are typically processed promptly by registered distributors and exporters in India.

Q: What are the storage recommendations for Erlotinib Tablets IP?

A: Store the tablets at room temperature, below 30C, in a dry place and away from moisture to preserve their potency and shelf life.

Q: Where is Erlotinib Tablets IP approved for use and distribution?

A: This product is approved and widely distributed throughout India, complying with national regulatory standards.

Q: What are the benefits of choosing this formulation?

A: Erlotinib Tablets IP offers a film-coated, easy-to-swallow formulation, a fresh odorless profile, and reliable efficacy, making treatment both convenient and effective.

Tell us about your requirement